Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic ITK inhibitors for treating inflammation and cancer

Heterocyclic ITK inhibitors for treating inflammation and cancer

US Patent 9695200 · Granted Jul 4, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of synthesizing substituted pyridinone-pyridinyl compounds2025
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2025
Pyrrolopyrimidine ITK inhibitors2025
Pyrrolopyrimidine ITK inhibitors2025
Pyrrolopyrimidine ITK inhibitors2025
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s2025
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s2025
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s2025
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Pyrrolopyrimidine ITK inhibitors2023
Pyrrolopyrimidine ITK inhibitors2023
Pyrrolopyrimidine ITK inhibitors2023